Skip to main content
. 2017 Mar 29;17:229. doi: 10.1186/s12885-017-3186-8

Fig. 1.

Fig. 1

Design of the PANCALYZE trial: Tumor tissue samples are collected during surgery. Biomarker expression of CXCR4, SMAD4, SOX9 and IFIT3 will be assessed using immunohistochemistry. The patients are followed up to analyze if CXCR4+SMAD4SOX9+IFIT3+ tumors will develop metastatic spread